BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$314.94 USD
+4.91 (1.58%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $315.00 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/24/2024
Time: -- |
9/2024 | $2.42 | -11.80% |
Earnings Summary
For their last quarter, BioRad Laboratories (BIO) reported earnings of $3.11 per share, beating the Zacks Consensus Estimate of $2.12 per share. This reflects a positive earnings surprise of 46.70%. Look out for BIO's next earnings release expected on October 24, 2024. For the next earning release, we expect the company to report earnings of $2.42 per share, reflecting a year-over-year increase of 3.86%.
Earnings History
Price & Consensus
Zacks News for BIO
Bio-Rad (BIO) Faces Low BioPharma Demand, Competitive Pressure
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services